0001782206-20-000002.txt : 20201023 0001782206-20-000002.hdr.sgml : 20201023 20201022194505 ACCESSION NUMBER: 0001782206-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20201023 DATE AS OF CHANGE: 20201022 EFFECTIVENESS DATE: 20201023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aditum Bio Fund 1, L.P. CENTRAL INDEX KEY: 0001782206 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-344544 FILM NUMBER: 201255769 BUSINESS ADDRESS: STREET 1: 1111 BROADWAY, SUITE 1300 CITY: OAKLAND STATE: CA ZIP: 94607 BUSINESS PHONE: (650) 843-5000 MAIL ADDRESS: STREET 1: 1111 BROADWAY, SUITE 1300 CITY: OAKLAND STATE: CA ZIP: 94607 D/A 1 primary_doc.xml X0708 D/A LIVE 0001782206 Aditum Bio Fund 1, L.P. 1111 BROADWAY, SUITE 1300 OAKLAND CA CALIFORNIA 94607 (650) 843-5000 DELAWARE None None Limited Partnership true 2019 N/A Aditum Bio GP 1, LLC 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director The General Partner of the Issuer (the "General Partner") Joseph Jimenez 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Managing Director of the General Partner of the Issuer Mark Fishman 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Co-Founder and Chairman of the Scientific Advisory Board Paul Sekhri 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Managing Director of the General Partner of the Issuer N/A TrialSpark, Inc. 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Managing Director of the General Partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 true 0001782206-19-000002 2019-07-19 false true false 0 133040000 133040000 0 false 26 0 0 0 The General Partner of the Issuer (or an affiliate thereof) is entitled to a management fee. false Aditum Bio Fund 1, L.P. /s/Joseph Jimenez Joseph Jimenez Managing Director of the General Partner of the Issuer 2020-10-22